Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

RNLX

Renalytix Plc ADR

May 10 • 04:00PM ET

0.6170

Dollar change -0.0164
Percentage change -2.59	%

Healthcare • Health Information Services • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.91	Insider Own	-	Shs Outstand	46.89M	Perf Week	-11.87%
Market Cap	47.62M	Forward P/E	-	EPS next Y	-0.48	Insider Trans	-	Shs Float	46.30M	Perf Month	-33.51%
Income	-41.85M	PEG	-	EPS next Q	-0.09	Inst Own	11.24%	Short Float	1.36%	Perf Quarter	61.90%
Sales	2.41M	P/S	19.76	EPS this Y	-5.69%	Inst Trans	-9.75%	Short Ratio	0.34	Perf Half Y	-36.42%
Book/sh	-0.16	P/B	-	EPS next Y	19.42%	ROA	-199.59%	Short Interest	0.63M	Perf Year	-74.61%
Cash/sh	0.07	P/C	8.47	EPS next 5Y	-	ROE	-9009.47%	52W Range	0.24 - 4.04	Perf YTD	58.21%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-134.94%	ROI	-	52W High	-84.72%	Beta	3.02
Dividend TTM	-	Quick Ratio	0.59	Sales past 5Y	22.75%	Gross Margin	6.31%	52W Low	151.94%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	0.59	EPS Y/Y TTM	20.51%	Oper. Margin	-1579.88%	RSI (14)	37.76	Volatility	6.35% 10.64%
Employees	-	Debt/Eq	-	Sales Y/Y TTM	-36.65%	Profit Margin	-1736.47%	Recom	1.00	Target Price	4.15
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	37.43%	Payout	-	Rel Volume	0.13	Prev Close	0.63
Sales Surprise	-7.14%	EPS Surprise	0.22%	Sales Q/Q	-40.52%	Earnings	May 15 BMO	Avg Volume	1.85M	Price	0.62
SMA20	-15.39%	SMA50	-29.14%	SMA200	-47.31%	Trades		Volume	235,765	Change	-2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-18-22	Initiated	H.C. Wainwright	Buy	$30
Jan-04-22	Initiated	BTIG Research	Buy	$24
Oct-04-21	Initiated	Guggenheim	Buy	$28
Jul-02-21	Initiated	Berenberg	Buy	$38
Aug-11-20	Initiated	Stifel	Buy

May-09-24 07:00AM	Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 (GlobeNewswire)
Apr-08-24 07:00AM	Renalytix Announces Financing with Expected Size of up to $4 Million (GlobeNewswire)
Mar-25-24 03:58PM	3 Ridiculously Enticing Stocks to Buy for Under a Buck (InvestorPlace) -8.11%
Mar-14-24 07:00AM	KidneyIntelX included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) (GlobeNewswire) +9.19%
Feb-15-24 07:00AM	Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 (GlobeNewswire) -35.10%
09:00AM	Loading…
Feb-09-24 09:00AM	Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -29.61%
Jan-10-24 07:00AM	New published data demonstrates KidneyIntelX has broad implications for winning war on chronic kidney disease (GlobeNewswire) -14.94%
Nov-14-23 07:00AM	Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 (GlobeNewswire) -37.51%
Nov-07-23 07:00AM	Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14 (GlobeNewswire)
Oct-16-23 12:00PM	What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock (Zacks) +9.48%
Oct-06-23 07:00AM	US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix (GlobeNewswire) -7.52%
Oct-05-23 09:35AM	Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -10.74%
Oct-03-23 08:45AM	Renalytix Plc (NASDAQ:RNLX) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.33%
Sep-28-23 07:00AM	Renalytix Reports Full Year Fiscal 2023 Results (GlobeNewswire) -22.96%
Sep-25-23 07:00AM	Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 (GlobeNewswire) -5.96%
07:00AM	Loading…
Sep-07-23 07:00AM	Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer (GlobeNewswire) -6.32%
Aug-03-23 07:00AM	Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd (GlobeNewswire)
Jul-21-23 07:00AM	Renalytix Announces Middle East Distribution Agreement with Vector Pharma (GlobeNewswire) +7.60%
Jul-07-23 07:00AM	Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions (GlobeNewswire) +11.15%
Jul-03-23 07:00AM	Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors (GlobeNewswire) +5.82%
Jun-29-23 06:01PM	FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease (GlobeNewswire)
Jun-15-23 07:00AM	KidneyIntelX Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences (GlobeNewswire) +9.72%
Jun-13-23 12:28PM	Renalytix Plc (NASDAQ:RNLX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Jun-05-23 07:00AM	Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9 (GlobeNewswire) -7.98%
May-25-23 07:00AM	Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes (GlobeNewswire)
Apr-19-23 07:00AM	New Published Real-World Evidence Shows KidneyIntelX Utility (GlobeNewswire)
Apr-12-23 07:00AM	Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting (GlobeNewswire)
Apr-06-23 12:24PM	Renalytix Plc (NASDAQ:RNLX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Mar-22-23 07:00AM	Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 (GlobeNewswire)
Feb-09-23 07:00AM	Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -5.14%
07:00AM	Loading…
Feb-08-23 07:00AM	Renalytix announces a c.$20.3 million private placement (GlobeNewswire)
Jan-26-23 07:00AM	Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States (GlobeNewswire)
Jan-09-23 07:00AM	Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems (GlobeNewswire) +5.53%
Dec-07-22 02:12PM	Renalytix Plc (NASDAQ:RNLX) Q1 2023 Earnings Call Transcript (Insider Monkey) -9.50%
Dec-01-22 07:00AM	Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes (GlobeNewswire)
Nov-30-22 08:30AM	Edited Transcript of RENX.L earnings conference call or presentation 30-Nov-22 1:30pm GMT (Thomson Reuters StreetEvents) +7.98%
Nov-29-22 07:00AM	Published Real World Evidence Demonstrates KidneyIntelX Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease (GlobeNewswire) +24.50%
Nov-22-22 07:00AM	Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30 (GlobeNewswire)
Nov-03-22 07:00AM	Renalytix to Present at Stifel Healthcare Conference (GlobeNewswire)
Oct-31-22 07:00AM	Renalytix Reports Full Year Fiscal 2022 Results (GlobeNewswire) +16.77%
Oct-24-22 07:00AM	Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31 (GlobeNewswire) -5.78%
Oct-17-22 07:00AM	KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology (GlobeNewswire) -8.86%
Sep-20-22 07:00AM	Renalytix Announces Change to Board of Directors (GlobeNewswire)
Sep-08-22 07:00AM	Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-08-22 07:00AM	Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX with Primary Care Physicians (GlobeNewswire)
Jun-30-22 07:00AM	Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022 (GlobeNewswire) -38.29%
Jun-27-22 12:13PM	Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains? (Zacks) -9.41%
Jun-23-22 07:00AM	Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30 (GlobeNewswire) +12.12%
Jun-10-22 07:00AM	1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease Patients (GlobeNewswire) -5.35%
Jun-09-22 06:45AM	3 Penny Stocks That Wall Street Thinks Are Undervalued (InvestorPlace)
Jun-08-22 07:00AM	Renalytix to Present at 42nd Annual William Blair Growth Stock Conference (GlobeNewswire) +12.17%
Jun-06-22 07:00AM	KidneyIntelX Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort (GlobeNewswire) -13.13%
Jun-02-22 07:00AM	Renalytix Announces Two Data Presentations on KidneyIntelX at American Diabetes Association 82nd Scientific Sessions® (GlobeNewswire) +9.31%
May-12-22 01:00PM	AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors (GlobeNewswire) +7.82%
Apr-08-22 07:00AM	Renalytix plc successful completion of $30.0 million financing package (GlobeNewswire)
07:00AM	Renalytix plc Issue of shares (GlobeNewswire)
Mar-31-22 07:05AM	Renalytix announces a $30.0 million financing package (GlobeNewswire)
07:00AM	Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022 (GlobeNewswire)
Mar-30-22 07:00AM	Confirmation of Appointment of Timothy Scannell to Renalytix Board of Directors (GlobeNewswire)
Mar-29-22 07:00AM	Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes (GlobeNewswire) +17.52%
Mar-25-22 07:00AM	Renalytix to Report Second Quarter and First Half Fiscal Year 2022 Financial Results on March 31 (GlobeNewswire) -8.03%
Mar-09-22 07:00AM	Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform (GlobeNewswire)
Feb-24-22 07:00AM	KidneyIntelX Clinical Results Presented at World Congress of Nephrology Demonstrate Improved Prediction of Kidney Function Over Standard of Care (GlobeNewswire)
Feb-22-22 07:30AM	Renalytix to Present at Cowen 42nd Annual Health Care Conference (GlobeNewswire)
07:00AM	Renalytix to Appoint Timothy Scannell to Board of Directors (GlobeNewswire)
Jan-27-22 07:00AM	Renalytix to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -6.46%
Jan-20-22 07:47AM	Renalytix AI PLC Sponsored ADR (RNLX) Surges 10.4%: Is This an Indication of Further Gains? (Zacks)
Jan-11-22 08:15AM	Positive Study Results Published for KidneyIntelX in Monitoring Patient Response to New Drug Therapy (GlobeNewswire) +8.09%
Jan-10-22 07:00AM	Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast (GlobeNewswire)
Jan-07-22 07:00AM	Renalytix Appoints Jean M. Casner as Chief Human Resources Officer (GlobeNewswire)
Jan-05-22 07:00AM	Renalytix to Present at 40th Annual J.P. Morgan Virtual Healthcare Conference (GlobeNewswire)
Jan-04-22 11:17AM	Renalytix Ends Down Slightly After ADA Joint Program and Buy Rating (Investing.com)
07:00AM	American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population (GlobeNewswire)
Dec-02-21 07:00AM	Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7 (GlobeNewswire) -5.99%
Nov-20-21 06:09AM	3 Small-Cap Stocks to Buy Now and Hold for the Long Haul (Motley Fool)
Nov-10-21 07:00AM	Renalytix Convenes Expert Panel at VA Healthcare Summit (GlobeNewswire) -6.61%
Nov-09-21 07:00AM	St. Josephs Health and Renalytix Partner to Advance Value-Based Kidney Health in New York (GlobeNewswire)
Oct-25-21 01:53PM	Heres Why Renalytix Plc (RNLX) Landed in Algers Top Detractor List (Insider Monkey)
Oct-21-21 07:00AM	Renalytix Reports Full Year Fiscal 2021 Results (GlobeNewswire) +5.59%
Oct-08-21 07:00AM	Renalytix to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results on October 21 (GlobeNewswire)
Oct-07-21 07:00AM	Renalytix Launching KidneyIntelX in Veterans Health Administration Hospitals (GlobeNewswire)
06:39AM	3 Growth Stocks Wall Street Thinks Could Rise 50% or More (Motley Fool)
Sep-29-21 01:14PM	Hedge Funds Are Piling Into Renalytix Plc (RNLX) (Insider Monkey)
Sep-14-21 07:00AM	Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX Enabled Health Care Model (GlobeNewswire) -12.45%
Sep-09-21 06:03AM	3 High-Growth Healthcare Stocks to Buy in September (Motley Fool) -5.53%
Sep-03-21 07:00AM	Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference (GlobeNewswire)
Aug-30-21 07:00AM	Renalytix Appoints Daniel J. Levangie to its Board of Directors (GlobeNewswire) +11.81%
06:36AM	3 High-Growth Stocks That Could Soar by 30% or Better According to Wall Street (Motley Fool)
Aug-26-21 07:00AM	Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX Testing at Primary Care Level (GlobeNewswire) +7.36%
Aug-03-21 06:16AM	3 High-Growth Healthcare Stocks to Buy in August (Motley Fool) -5.04%
Jul-28-21 07:00AM	Renalytix Appoints Ann Berman to its Board of Directors (GlobeNewswire) +7.45%
Jul-26-21 07:00AM	Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference (GlobeNewswire)
Jul-22-21 07:00AM	Renalytix Appoints Joseph Hutson Vice President of Global Quality and Regulatory (GlobeNewswire)
Jul-16-21 06:19AM	3 High-Growth Stocks Truly Headed for the Moon (Motley Fool)
Jul-11-21 08:43AM	3 Top Life Science Stocks to Buy on Sale Right Now (Motley Fool)
Jun-28-21 07:00AM	KidneyIntelX Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time (GlobeNewswire)
Jun-15-21 07:00AM	Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2021 (GlobeNewswire)
Jun-10-21 08:00AM	Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update (GlobeNewswire)
Jun-07-21 07:00AM	Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment (GlobeNewswire)
Jun-03-21 07:00AM	Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care (GlobeNewswire)

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RNLX

Renalytix Plc ADR

Upgrade your FINVIZ experience